Literature DB >> 28199491

Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.

Frederic Lamoth1,2,3,4, Shimin J Chung1,5, Lauro Damonti3, Barbara D Alexander1,2.   

Abstract

Breakthrough invasive mold infections (IMIs) that occur during posaconazole or voriconazole prophylaxis are rare complications for which epidemiological data are lacking. This retrospective analysis comparing 24 microbiologically documented breakthrough with 66 nonbreakthrough IMIs shows a shift towards non-Aspergillus molds with a significantly increased proportion of rare multidrug-resistant molds.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Aspergillus ustus; Scopulariopsis.; antifungal prophylaxis; invasive aspergillosis; mucormycosis

Mesh：

Substances：

Year:  2017        PMID： 28199491     DOI： 10.1093/cid/cix130

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  29 in total

1.  Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis.

Authors:  Arthur W Baker; Eileen K Maziarz; Christopher J Arnold; Melissa D Johnson; Adrienne D Workman; John M Reynolds; John R Perfect; Barbara D Alexander
Journal:  Clin Infect Dis       Date:  2020-01-01       Impact factor: 9.079

Review 2.  Diagnosis and Treatment of Acute Invasive Fungal Sinusitis in Cancer and Transplant Patients.

Authors:  Monica Fung; Jennifer Babik; Ian M Humphreys; Greg E Davis
Journal:  Curr Infect Dis Rep       Date:  2019-11-26       Impact factor: 3.725

Review 3.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

4.  Breakthrough Invasive Fungal Infections on Isavuconazole Prophylaxis and Treatment: What Is Happening in the Real-World Setting?

Authors:  Monica Fung; Brian S Schwartz; Sarah B Doernberg; Charles Langelier; Mimi Lo; Larissa Graff; Marisela Tan; Aaron C Logan; Peter Chin-Hong; Jennifer M Babik
Journal:  Clin Infect Dis       Date:  2018-09-14       Impact factor: 9.079

5.  Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia.

Authors:  Anastasia Wasylyshyn; Kathleen A Linder; Caroline G Castillo; Shiwei Zhou; Carol A Kauffman; Marisa H Miceli
Journal:  Mycopathologia       Date:  2020-01-14       Impact factor: 2.574

6.  Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus.

Authors:  E Glampedakis; A T Coste; M Aruanno; D Bachmann; E Delarze; V Erard; F Lamoth
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 7.  Fungal infections in lung transplantation.

Authors:  Palash Samanta; Cornelius J Clancy; M Hong Nguyen
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

8.  Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.

Authors:  J Kevin Hicks; Rod E Quilitz; Rami S Komrokji; Timothy E Kubal; Jeffrey E Lancet; Yanina Pasikhova; Dahui Qin; Wonhee So; Gisela Caceres; Kerry Kelly; Yasmina S Salchert; Kevin Shahbazian; Farnoosh Abbas-Aghababazadeh; Brooke L Fridley; Ana P Velez; Howard L McLeod; John N Greene
Journal:  Clin Pharmacol Ther       Date:  2019-11-01       Impact factor: 6.875

9.  Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole.

Authors:  Caitlin R Rausch; Adam J DiPippo; Prithviraj Bose; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

10.  Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions.

Authors:  Michail S Lionakis; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.